Personalized Vaccine For 'Dead...
Join researchers working on pediatric cancer at DMM's Journal Meeting this October at Nationwide Children’s Hospital, USA.
Organisers: James Amatruda, Pratiti (Mimi) Bandopadhayay, Ana Banito & Elaine Mardis
Register at https://tinyurl.com/bddksc4v
Recurrent dysphagia after esophageal SEMS?
👉 Don’t assume tumor progression.
📸 X-ray: Stent migrated into stomach
💡 Most common cause: stent migration
🔧 Next step:
✔ Endoscopy
✔ Retrieval ± re-stenting (better fixation)
🎯 Restore swallowing, improve QOL
#EsophagealCancer #GI #Endoscopy #Oncology #Dysphagia #GastroAGI

Home > Blog > Advanced Therapies & TechnologyKey Takeaways • In 2025, China's National Medical Products Administration (NMPA) approved a record 120 new drugs, including 76 innovative therapies and 11 First-in-Class molecules. • Novel VHH-based CAR-T therapies (such as IMC002 targeting CLDN18.2) are demonstrating substantial objective response rates in clinical trials for advanced gastrointestinal cancers. • Effective May 2026, the new "Regulations on the Administration of Clinical Research and C